NASDAQ: ADILAdial Pharmaceuticals Inc Stock Ownership - Who owns Adial Pharmaceuticals?
Insider buying vs selling
Have Adial Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Cary J. Claiborne | Chief Executive Officer | 2022-09-20 | 75,000 | $0.42 | $31.50kBuy |
| Cary J. Claiborne | Chief Executive Officer | 2022-09-19 | 25,000 | $0.43 | $10.73kBuy |
ADIL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ADIL insiders and whales buy or sell their stock.
ADIL Shareholders
What type of owners hold Adial Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Cary J. Claiborne | 5.33% | 1,520,000 | $422.56k | Insider |
| William B. Stilley Iii | 4.89% | 1,393,920 | $387.51k | Insider |
| Manchester Capital Management LLC | 4.22% | 1,202,452 | $334.28k | Institution |
| Bankole A. Johnson | 3.06% | 872,720 | $242.62k | Insider |
| James W. Newman Jr. | 1.54% | 438,742 | $121.97k | Insider |
| Joseph Truluck | 0.93% | 265,139 | $73.71k | Insider |
| Blackrock Inc | 0.79% | 225,855 | $62.79k | Institution |
| Susquehanna International Group LLP | 0.78% | 222,283 | $61.79k | Institution |
| Vanguard Group Inc | 0.71% | 203,358 | $56.53k | Institution |
| Kevin Schuyler | 0.52% | 147,242 | $40.93k | Insider |
ADIL vs Biotech Stocks
Adial Pharmaceuticals Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.